In January 2016, the FDA gave approval to a once-daily pill combination of elbasvir and grazoprevir called Zepatier. It has been shown to have the ability to cure the disease in almost 100% of those treated. It follows the success of another once-daily treatment called Harvoni that cures the disease in most people in 8-12 weeks. Harvoni combines two drugs: sofosbuvir (Sovaldi) and ledipasvir. In clinical trials, the most common side effects in both drugs were fatigue and headache.
Other fairly
recent drugs are ombitasvir-paritaprevir-dasabuvir-ritonavir (Viekira Pak), ombitasvir-paritaprevir-ritonavir (Technivie) and daclastasvir (Daklinza) which do not require interferon and cure more people in less time. Ombitasvir-paritaprevir-dasabuvir-ritonavir and ombitasvir-paritaprevir-ritonavir carry an FDA warning of severe liver injury if given to someone with underlying severe liver disease. All of these medicines are quite expensive.
Instead, your doctor could recommend a combination of boceprevir (Victrelis), simeprevir (Olysio), sofosbuvir (Sovaldi), or ), or telaprevir (Incivek) with interferon (which you take by injection), and ribavirin (which comes as a liquid, tablet, or capsule).
Interferon and ribavirin used to be the main treatments for hepatitis C. They can have side effects like fatigue, flu-like symptoms, anemia, skin rash, mild anxiety, depression,nausea, and diarrhea.
Comment Reply
Hello Anonymous,
Welcome to EmpowHER.
Are you asking about treatment of Hepatitis C?
In January 2016, the FDA gave approval to a once-daily pill combination of elbasvir and grazoprevir called Zepatier. It has been shown to have the ability to cure the disease in almost 100% of those treated. It follows the success of another once-daily treatment called Harvoni that cures the disease in most people in 8-12 weeks. Harvoni combines two drugs: sofosbuvir (Sovaldi) and ledipasvir. In clinical trials, the most common side effects in both drugs were fatigue and headache.
Other fairly
recent drugs are ombitasvir-paritaprevir-dasabuvir-ritonavir (Viekira Pak), ombitasvir-paritaprevir-ritonavir (Technivie) and daclastasvir (Daklinza) which do not require interferon and cure more people in less time. Ombitasvir-paritaprevir-dasabuvir-ritonavir and ombitasvir-paritaprevir-ritonavir carry an FDA warning of severe liver injury if given to someone with underlying severe liver disease. All of these medicines are quite expensive.
Instead, your doctor could recommend a combination of boceprevir (Victrelis), simeprevir (Olysio), sofosbuvir (Sovaldi), or ), or telaprevir (Incivek) with interferon (which you take by injection), and ribavirin (which comes as a liquid, tablet, or capsule).
Interferon and ribavirin used to be the main treatments for hepatitis C. They can have side effects like fatigue, flu-like symptoms, anemia, skin rash, mild anxiety, depression,nausea, and diarrhea.
Regards,
July 4, 2017 - 12:19pmMaryann
This Comment
Reply